FORTRESS BIOTECHPRFA (Germany) Probability of Future Stock Price Finishing Under 0.26
| CNB0 Stock | EUR 6.60 0.45 6.38% |
FORTRESS |
FORTRESS BIOTECHPRFA Target Price Odds to finish below 0.26
The tendency of FORTRESS Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to € 0.26 or more in 90 days |
| 6.60 | 90 days | 0.26 | near 1 |
Based on a normal probability distribution, the odds of FORTRESS BIOTECHPRFA to drop to € 0.26 or more in 90 days from now is near 1 (This FORTRESS BIOTECHPRFA 25 probability density function shows the probability of FORTRESS Stock to fall within a particular range of prices over 90 days) . Probability of FORTRESS BIOTECHPRFA price to stay between € 0.26 and its current price of €6.6 at the end of the 90-day period is about 64.74 .
Assuming the 90 days trading horizon FORTRESS BIOTECHPRFA has a beta of 0.0082 suggesting as returns on the market go up, FORTRESS BIOTECHPRFA average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding FORTRESS BIOTECHPRFA 25 will be expected to be much smaller as well. Additionally FORTRESS BIOTECHPRFA 25 has an alpha of 0.6358, implying that it can generate a 0.64 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). FORTRESS BIOTECHPRFA Price Density |
| Price |
Predictive Modules for FORTRESS BIOTECHPRFA
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as FORTRESS BIOTECHPRFA. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.FORTRESS BIOTECHPRFA Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. FORTRESS BIOTECHPRFA is not an exception. The market had few large corrections towards the FORTRESS BIOTECHPRFA's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold FORTRESS BIOTECHPRFA 25, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of FORTRESS BIOTECHPRFA within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.64 | |
β | Beta against Dow Jones | 0.01 | |
σ | Overall volatility | 0.87 | |
Ir | Information ratio | 0.09 |
FORTRESS BIOTECHPRFA Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of FORTRESS BIOTECHPRFA for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for FORTRESS BIOTECHPRFA can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| FORTRESS BIOTECHPRFA had very high historical volatility over the last 90 days | |
| FORTRESS BIOTECHPRFA has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 77.61 M. Net Loss for the year was (42.98 M) with loss before overhead, payroll, taxes, and interest of (85.66 M). | |
| FORTRESS BIOTECHPRFA 25 has accumulated about 289.9 M in cash with (83.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.98. |
FORTRESS BIOTECHPRFA Technical Analysis
FORTRESS BIOTECHPRFA's future price can be derived by breaking down and analyzing its technical indicators over time. FORTRESS Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of FORTRESS BIOTECHPRFA 25. In general, you should focus on analyzing FORTRESS Stock price patterns and their correlations with different microeconomic environments and drivers.
FORTRESS BIOTECHPRFA Predictive Forecast Models
FORTRESS BIOTECHPRFA's time-series forecasting models is one of many FORTRESS BIOTECHPRFA's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary FORTRESS BIOTECHPRFA's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about FORTRESS BIOTECHPRFA
Checking the ongoing alerts about FORTRESS BIOTECHPRFA for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for FORTRESS BIOTECHPRFA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| FORTRESS BIOTECHPRFA had very high historical volatility over the last 90 days | |
| FORTRESS BIOTECHPRFA has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 77.61 M. Net Loss for the year was (42.98 M) with loss before overhead, payroll, taxes, and interest of (85.66 M). | |
| FORTRESS BIOTECHPRFA 25 has accumulated about 289.9 M in cash with (83.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.98. |
Other Information on Investing in FORTRESS Stock
FORTRESS BIOTECHPRFA financial ratios help investors to determine whether FORTRESS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in FORTRESS with respect to the benefits of owning FORTRESS BIOTECHPRFA security.